OGN Latest Headlines

Organon Gains Strategic Edge with FDA Approval of First PERJETA Biosimilar POHERDY

Market Chameleon (Mon, 17-Nov 8:41 AM)

Adjusted Profitability Improves at Organon as Cost Controls Offset Modest Revenue Growth

Market Chameleon (Mon, 10-Nov 8:12 AM)

Organon Overhauls Leadership After Wholesaler Sales Investigation—Audit Finds Minimal Revenue Impact, Major Governance Actions

Market Chameleon (Mon, 27-Oct 8:26 AM)